NCT03333668 - Experimental fMRI Study of Guanfacine and Lisdexamfetamine in ADHD Adolescents | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2025

Conditions

ADHD

Interventions

DRUG

Lisdexamfetamine dimesylate

Lisdexamfetamine dimesylate (30mg for smaller, 50mg for larger boys) tablet

DRUG

Guanfacine Extended Release Oral Tablet

Guanfacine Extended Release (0.05mg/kg) tablet

DRUG

Placebo

Vitamin C (10mg) tablet

Trial Locations (1)

Institute of Psychiatry, Psychology & Neuroscience; King's College London, London